Company Active LTD

Company profile

Uniq Health Ltd

Homepage 2

Uniq Health Ltd is a UK company with status active founded in 2017 based in East of England.

CRN
10972015
Founded
2017
Age
8

Overview

Legal name
UNIQ HEALTH LTD
Region
East of England
Registered address
82B HIGH STREET
SAWSTON
CAMBRIDGE
ENGLAND
CB22 3HJ
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
-£135,076
Employees
4

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

03 Oct
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

19 Sep
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

25 Sep
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzNzIxNDE3M2FkaXF6a2N4

Published 25 Sep 2024 02:41

20 Sep
2017

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2020
Funded years
2020, 2023
Age at first award
3 years

Projects

2023 Collaborative R&D Lead participant

Improving NHS perimenopausal diagnosis and HRT prescription through AI, machine learning and big data

1 Apr 2023 to 30 Sep 2024

Awarded
£335,201
Total cost £478,858

On the 12th October the UK GOV the all-party parliamentary group on menopause (APPG) said that more needs to be done urgently to help women, including earlier screening , introducing fresh training on symptoms for health workers, and improving access to treatment. "Millions of women across the UK should be invited for an NHS health check at the age of 45 ...

2020 Collaborative R&D Lead participant

Automated, intelligent oral contraception prescribing via telemedicine - using AI to improve patient health outcomes and streamline time-intensive assessment processes, exacerbated by COVID-19

1 Dec 2020 to 30 Nov 2021

Awarded
£325,186
Total cost £406,483

Covid 19 has validated and compounded the need for improved efficiencies (identified within the NHS Long Term plan) via the urgent introduction of automation and the utilisation of Telemedicine where feasible to reduce strain on resources, especially with the prospect of a second wave/future spikes on the horizon. The ongoing impact of Covid-19 meant over...

Product types

Collaborative R&D